LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
Clinical trial NCT03684980 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03684980
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-14
- Primary completion
- 2027-11-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.